Vanguard Group Inc. Has $127.16 Million Holdings in Schrodinger, Inc. $SDGR

Vanguard Group Inc. decreased its holdings in shares of Schrodinger, Inc. (NASDAQ:SDGR) by 4.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,339,077 shares of the company’s stock after selling 277,572 shares during the quarter. Vanguard Group Inc. owned 8.61% of Schrodinger worth $127,162,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Massachusetts Financial Services Co. MA lifted its holdings in shares of Schrodinger by 38.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,072,433 shares of the company’s stock valued at $41,573,000 after buying an additional 577,899 shares during the last quarter. Capital Fund Management S.A. bought a new stake in Schrodinger during the 2nd quarter valued at approximately $1,486,000. Sumitomo Mitsui Trust Group Inc. increased its position in Schrodinger by 24.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,554,569 shares of the company’s stock worth $91,365,000 after acquiring an additional 904,619 shares during the period. Nikko Asset Management Americas Inc. raised its position in shares of Schrodinger by 7.2% during the second quarter. Nikko Asset Management Americas Inc. now owns 2,591,492 shares of the company’s stock valued at $52,089,000 after buying an additional 174,684 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC bought a new stake in shares of Schrodinger in the 3rd quarter worth approximately $1,732,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on SDGR shares. KeyCorp dropped their price objective on shares of Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, January 8th. TD Cowen restated a “buy” rating on shares of Schrodinger in a research note on Thursday, January 8th. UBS Group assumed coverage on Schrodinger in a report on Wednesday, January 7th. They set a “neutral” rating and a $18.00 price objective on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Schrodinger in a research report on Friday, January 9th. Finally, Wall Street Zen raised Schrodinger from a “sell” rating to a “hold” rating in a research note on Saturday, January 31st. Four investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $21.75.

Schrodinger Stock Performance

Shares of SDGR opened at $12.50 on Wednesday. The company has a market cap of $920.88 million, a price-to-earnings ratio of -8.80 and a beta of 1.57. The stock has a fifty day moving average price of $15.10 and a two-hundred day moving average price of $17.71. Schrodinger, Inc. has a 52-week low of $11.11 and a 52-week high of $27.63.

Schrodinger (NASDAQ:SDGR) last announced its earnings results on Wednesday, February 25th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.57. Schrodinger had a negative return on equity of 29.47% and a negative net margin of 40.37%.The company had revenue of $87.24 million during the quarter, compared to analyst estimates of $83.66 million. During the same period last year, the company posted ($0.24) earnings per share. The firm’s quarterly revenue was up 4.7% compared to the same quarter last year. As a group, research analysts predict that Schrodinger, Inc. will post -2.37 EPS for the current fiscal year.

Schrodinger Company Profile

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.